Neurological manifestations of coronavirus disease: a literature review
Keywords:COVID-19, Coronavirus, Neurological manifestations
In December 2019, coronavirus pandemic re-emerged. Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has been identified as the causation in series of acute pneumonia cases discovered in Wuhan in Hubei Province, China. This disease is officially named COVID-19 by WHO. Symptoms manifestation of COVID-19 range from fever, malaise, myalgia, headache, to respiratory system symptoms of cough, stuffy/runny nose, and difficulty breathing. In severe cases, it may result in ARDS. A case study has reported that COVID-19 may also have cardiovascular manifestation, i.e. life threatening arrhythmia. Although COVID-19 is a respiratory infection and cardiovascular event is the main cause of fatality, medical professionals must understand its neurological complications in order to reduce mortality rate in infected patients. Further researches on specific risk factors or determinant protective factors from the neurological symptoms are needed to reduce risk of complication in COVID-19 infection cases.
Adhikari SP, Meng S, Wu YJ, Mao YP, Ye RX, Wang QZ, et al. Epidemiology, causes, clinical manifestation and diagnosis, prevention and control of coronavirus disease (COVID-19) during the early outbreak period: a scoping review. Infectious diseases of poverty. 2020 Dec;9(1):1-2.
Novel Coronavirus Pneumonia Emergency Response Epidemiology Team. The epidemiological characteristics of an outbreak of 2019 novel coronavirus diseases (COVID-19) in China. Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Feb 17;41(2):145-51.
Coronavirus Disease 19 (COVID-19): situation report. World Health Organization. 2020. Available at: https://www.who.int/docs/default-source/coronaviruse/situation-reports/20200301-sitrep-41-covid-19.pdf. Accessed 05 February 2020.
Sun J, He WT, Wang L, Lai A, Ji X, Zhai X, et al. COVID-19: Epidemiology, Evolution, and Cross-Disciplinary Perspectives. Trends Mole Med. 2020.
Qiu H, Wu J, Hong L, Luo Y, Song Q, Chen D. Clinical and epidemiological features of 36 children with coronavirus disease 2019 (COVID-19) in Zhejiang, China: An observational cohort study. Lancet Infect Dis. 2020.
Cauchemez S, Fraser C, Van Kerkhove MD, Donnelly CA, Riley S, Rambaut A, et al. Middle East respiratory syndrome coronavirus: Quantification of the extent of the epidemic, surveillance biases, and transmissibility. Lancet Infect Dis. 2014.
Hageman JR. The coronavirus disease 2019 (COVID-19). Pediatric Annals. 2020.
Cascella M, Rajnik M, Cuomo A, Dulebohn SC, Di Napoli R. Features, Evaluation and Treatment Coronavirus (COVID-19). Stat Pearls. 2020.
Zheng YY, Ma YT, Zhang JY, Xie X. COVID-19 and the cardiovascular system. Nature Reviews Cardiol. 2020.
Wang HY, Xue-Lin Li Z-RY. Potential neurological symptoms of COVID-19. Sage Pub. 2020.
Mao L, Wang M, Chen S, He Q, Chang J, Hong C, et al. Neurological Manifestations of Hospitalized Patients with COVID-19 in Wuhan, China: a retrospective case series study. medrxiv. 2020;2020.
Guan W, Ni Z, Hu Y, Liang W, Ou C, He J, et al. Clinical characteristics of 2019 novel coronavirus infection in China. N Engl J Med. 2020.
Li YC, Bai WZ, Hashikawa T. The neuroinvasive potential of SARS-CoV2 may be at least partially responsible for the respiratory failure of COVID-19 patients. J Med Virol. 2020.
Filatov A, Sharma P, Hindi F, Espinosa PS. Neurological complications of coronavirus disease (COVID-19): encephalopathy. Cureus. 2020 Mar;12(3).
Poyiadji N, Shahin G, Noujaim D, Stone M, Patel S, Griffith B. COVID-19–associated acute hemorrhagic necrotizing encephalopathy: CT and MRI features. Radiology. 2020 Mar 31:201187.
Karimi N, Sharifi Razavi A, Rouhani N. Frequent Convulsive Seizures in an Adult Patient with COVID-19: A Case Report. Iranian Red Crescent Med J. 2020;22(3).
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet. 2020.